COMPANY PROFILE

Strand Diagnostics

Strand Diagnostics develops and markets the know error® system which utilizes bar coding and DNA testing to confirm surgical biopsy samples

Indianapolis, United StatesFounded 2009Biotech & Life Sciences

Valuation $100–250M Last recorded · 2012

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

At a glance

Status: Acquired
Founded: 2009
Headquarters: Indianapolis, United States
Employees: 9
Open positions: None listed
Dealroom signal: 85.7/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Testing, Biotechnology, Oncology, DNA, Surgery, Genetics and genomics, Health Diagnostics, Biotech and Pharma, Hard Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Feb 2020	$0	—	Undisclosed	—
SERIES A✓Equity / VC	Mar 2012	$30M	$120M	NantCell \| Nantworks	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Strand Diagnostics website traffic

Latest recorded traffic for Strand Diagnostics is 360 monthly website visits, down 46.3% over the last three months. Strand Diagnostics's team grew 50% over the past year.

Latest monthly visits360 3-month web change-46.3% 1-year team growth+50%

Monthly website visitsJan 2017–Jun 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ADArquer DiagnosticsArquer Diagnostics is a diagnostics company focused on the development and commercialisation of a non-invasive immunoassay diagnostic test	Sunderland, United Kingdom	Closed	3	$19M	—
GBGeneCast BiotechnologyIt is a Beijing cancer diagnosis company	Haidian, China	Operational
BGBlueprint GeneticsUses Next Generation Sequencing (NGS) to perform diagnostics on genetic diseases	Espoo, Finland	Operational
CDCNA DiagnosticsA molecular diagnostics company developing novel diagnostic tests for a spectrum of complex diseases	Calgary, Canada	Operational
BIBillionToOneThe only genetic testing platform that accurately and efficiently detects and measures disease at the molecular level	Menlo Park, United States	Operational
ANAnnoroadA leading developer and marketer on genomic innovation technologies for research and clinical market	Dongcheng District, China	Operational
MLMedGenome LabsA genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome	Foster City, United States	Operational
LOLoxo OncologyLoxo Oncology - Targeting Cancer with Strong Chemistry	Stamford, United States	Acquired